Cytoskeletal signaling in TGFβ-induced epithelial-mesenchymal transition

Cytoskeleton

Volumn 72, Issue 11, 2015, Pages 557-569

  Nalluri, Sandeep M ^a   O'Connor, Joseph W ^a   Gomez, Esther W ^a  

^a The Pennsylvania State University   (United States)

Author keywords

Cytoskeleton; Fibrosis; Mechanobiology; Metastasis; Motility

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALDESMON; CYTOSKELETON PROTEIN; EZRIN; FOCAL ADHESION KINASE; HYDROGEN PEROXIDE INDUCIBLE CLONE 5; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 3; MOESIN; MYOCARDIN; MYOSIN II; PDZ PROTEIN; RADIXIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TROPOMYOSIN; UNCLASSIFIED DRUG; ZYXIN;

CELL CYCLE PROGRESSION; CYTOSKELETON; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; INTERMEDIATE FILAMENT; INTRACELLULAR SIGNALING; MICROFILAMENT; PRIORITY JOURNAL; REVIEW; METABOLISM; METASTASIS; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CYTOSKELETON; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASM METASTASIS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84956772461     PISSN: 19493584     EISSN: 19493592     Source Type: Journal    
DOI: 10.1002/cm.21263     Document Type: Review

References (158)

1. Aparicio LA, Castosa R, Haz-Conde M, Rodríguez M, Blanco M, Valladares M, Figueroa A. 2014. Role of the microtubule-targeting drug vinflunine on cell-cell adhesions in bladder epithelial tumour cells. BMC Cancer 14:507
2. Aragona M, Panciera T, Manfrin A, Giulitti S, Michielin F, Elvassore N, Dupont S, Piccolo S. 2013. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell 154:1047-1059.
3. Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL. 2002. p38 mitogen-activated protein kinase is required for TGFβ-mediated fibroblastic transdifferentiation and cell migration. J Cell Sci 115:3193-3206.
4. Bakin AV, Safina A, Rinehart C, Daroqui C, Darbary H, Helfman DM. 2004. A critical role of tropomyosins in TGF-β regulation of the actin cytoskeleton and cell motility in epithelial cells. Mol Biol Cell 15:4682-4694.
5. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. 2000. Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275:36803-36810.
6. Beach JR, Hussey GS, Miller TE, Chaudhury A, Patel P, Monslow J, Zheng Q, Keri RA, Reizes O, Bresnick AR. 2011. Myosin II isoform switching mediates invasiveness after TGF-β-induced epithelial-mesenchymal transition. Proc Natl Acad Sci U S A 108:17991-17996.
7. Beckerle MC. 1998. Spatial control of actin filament assembly: Lessons from Listeria. Cell 95:741-748.
8. Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, Engel ME, Arteaga CL, Moses HL. 2001a. Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 12:27-36.
9. Bhowmick NA, Zent R, Ghiassi M, McDonnell M, Moses HL. 2001b. Integrin β1 signaling is necessary for transforming growth factor-β activation of p38MAPK and epithelial plasticity. J Biol Chem 276:46707-46713.
10. Bianchi-Smiraglia A, Kunnev D, Limoge M, Lee A, Beckerle MC, Bakin AV. 2013. Integrin-beta5 and zyxin mediate formation of ventral stress fibers in response to transforming growth factor beta. Cell Cycle 12:3377-3389.
11. Bindels S, Mestdagt M, Vandewalle C, Jacobs N, Volders L, Noel A, van Roy F, Berx G, Foidart JM, Gilles C. 2006. Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene 25:4975-4985.
12. Blue EK, Goeckeler ZM, Jin Y, Hou L, Dixon SA, Herring BP, Wysolmerski RB, Gallagher PJ. 2002. 220-and 130-kDa MLCKs have distinct tissue distributions and intracellular localization patterns. Am J Physiol Cell Physiol 282:C451-C460.
13. Brown AC, Fiore VF, Sulchek TA, Barker TH. 2013. Physical and chemical microenvironmental cues orthogonally control the degree and duration of fibrosis-associated epithelial-to-mesenchymal transitions. J Pathol 229:25-35.
14. Buckley ST, Medina C, Davies AM, Ehrhardt C. 2012. Cytoskeletal re-arrangement in TGF-beta1-induced alveolar epithelial-mesenchymal transition studied by atomic force microscopy and high-content analysis. Nanomedicine 8:355-364.
15. Chang F, Steelman L, Lee J, Shelton J, Navolanic P, Blalock W, Franklin R, McCubrey J. 2003. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 17:1263-1293.
16. Charbonney E, Speight P, Masszi A, Nakano H, Kapus A. 2011. beta-catenin and Smad3 regulate the activity and stability of myocardin-related transcription factor during epithelial-myofibroblast transition. Mol Biol Cell 22:4472-4485.
17. Chen J, Li H, SundarRaj N, Wang JHC. 2007. Alpha-smooth muscle actin expression enhances cell traction force. Cell Motil Cytoskeleton 64:248-257.
18. Chen MJ, Gao XJ, Xu LN, Liu TF, Liu XH, Liu LX. 2014. Ezrin is required for epithelial-mesenchymal transition induced by TGF-beta1 in A549 cells. Int J Oncol 45:1515-1522.
19. Chew T-L, Masaracchia RA, Goeckeler ZM, Wysolmerski RB. 1998. Phosphorylation of non-muscle myosin II regulatory light chain by p21-activated kinase (γ-PAK). J Muscle Res Cell Motil 19:839-854.
20. Cho HJ, Yoo J. 2007. Rho activation is required for transforming growth factor-β-induced epithelial-mesenchymal transition in lens epithelial cells. Cell Biol Int 31:1225-1230.
21. Choi CK, Vicente-Manzanares M, Zareno J, Whitmore LA, Mogilner A, Horwitz AR. 2008. Actin and α-actinin orchestrate the assembly and maturation of nascent adhesions in a myosin II motor-independent manner. Nat Cell Biol 10:1039-1050.
22. Collins JH, Korn ED. 1980. Actin activation of Ca2+-sensitive Mg2+-ATPase activity of Acanthamoeba myosin II is enhanced by dephosphorylation of its heavy chains. J Biol Chem 255:8011-8014.
23. Cooper JA. 2002. Actin dynamics: Tropomyosin provides stability. Curr Biol 12:R523-R525.
24. Coulombe PA, Omary MB. 2002. 'Hard'and 'soft'principles defining the structure, function and regulation of keratin intermediate filaments. Curr Opin Cell Biol 14:110-122.
25. Davies M, Robinson M, Smith E, Huntley S, Prime S, Paterson I. 2005. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways. J Cell Biochem 95:918-931.
26. De Craene B, Gilbert B, Stove C, Bruyneel E, van Roy F, Berx G. 2005. The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. Cancer Res 65:6237-6244.
27. Deakin NO, Ballestrem C, Turner CE. 2012. Paxillin and Hic-5 interaction with vinculin is differentially regulated by Rac1 and RhoA. PLoS One 7:e37990
28. Deckers M, van Dinther M, Buijs J, Que I, Löwik C, van der Pluijm G, ten Dijke P. 2006. The tumor suppressor Smad4 is required for transforming growth factor β-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res 66:2202-2209.
29. Derynck R, Akhurst RJ. 2007. Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat Cell Biol 9:1000-1004.
30. Destaing O, Block MR, Planus E, Albiges-Rizo C. 2011. Invadosome regulation by adhesion signaling. Curr Opin Cell Biol 23:597-606.
31. Diepenbruck M, Waldmeier L, Ivanek R, Berninger P, Arnold P, van Nimwegen E, Christofori G. 2014. Tead2 expression levels control the subcellular distribution of Yap and Taz, zyxin expression and epithelial-mesenchymal transition. J Cell Sci 127:1523-1536.
32. Dong C, Li Z, Alvarez R, Jr., Feng XH, Goldschmidt-Clermont PJ. 2000. Microtubule binding to Smads may regulate TGF beta activity. Mol Cell 5:27-34.
33. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M, Bicciato S, et al. 2011. Role of YAP/TAZ in mechanotransduction. Nature 474:179-183.
34. Eckes B, Colucci-Guyon E, Smola H, Nodder S, Babinet C, Krieg T, Martin P. 2000. Impaired wound healing in embryonic and adult mice lacking vimentin. J Cell Sci 113:2455-2462.
35. Edlund S, Landström M, Heldin C-H, Aspenström P. 2002. Transforming growth factor-β-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Mol Biol Cell 13:902-914.
36. Elberg G, Chen L, Elberg D, Chan MD, Logan CJ, Turman MA. 2008. MKL1 mediates TGF-β1-induced α-smooth muscle actin expression in human renal epithelial cells. Am J Physiol Renal Physiol 294:F1116-F1128.
37. Ellenrieder V, Hendler SF, Boeck W, Seufferlein T, Menke A, Ruhland C, Adler G, Gress TM. 2001. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res 61:4222-4228.
38. Elliott BE, Hung WL, Boag AH, Tuck AB. 2002. The role of hepatocyte growth factor (scatter factor) in epithelial-mesenchymal transition and breast cancer. Can J Physiol Pharmacol 80:91-102.
39. Espinosa Neira R, Perez Salazar E. 2012. Native type IV collagen induces an epithelial to mesenchymal transition-like process in mammary epithelial cells MCF10A. Int J Biochem Cell Biol 44:2194-2203.
40. Fan LZ, Sebe A, Peterfi Z, Masszi A, Thirone ACP, Rotstein OD, Nakano H, McCulloch CA, Szaszi K, Mucsi I, et al. 2007. Cell contact-dependent epithelial-myofibroblast kinase-phospho-myosin regulation of transition via the Rho-Rho pathway. Mol Biol Cell 18:1083-1097.
41. Fehon RG, McClatchey AI, Bretscher A. 2010. Organizing the cell cortex: the role of ERM proteins. Nat Rev Mol Cell Biol 11:276-287.
42. Fortier A-M, Asselin E, Cadrin M. 2013. Keratin 8 and 18 loss in epithelial cancer cells increases collective cell migration and cisplatin sensitivity through claudin1 up-regulation. J Biol Chem 288:11555-11571.
43. Gabelt BT, Hu YJ, Vittitow JL, Rasmussen CR, Grosheva I, Bershadsky AD, Geiger B, Borras T, Kaufman PL. 2006. Caldesmon transgene expression disrupts focal adhesions in HTM cells and increases outflow facility in organ-cultured human and monkey anterior segments. Exp Eye Res 82:935-944.
44. Giacomini MM, Travis MA, Kudo M, Sheppard D. 2012. Epithelial cells utilize cortical actin/myosin to activate latent TGF-beta through integrin alpha(v)beta(6)-dependent physical force. Exp Cell Res 318:716-722.
45. Gilles C, Polette M, Zahm JM, Tournier JM, Volders L, Foidart JM, Birembaut P. 1999. Vimentin contributes to human mammary epithelial cell migration. J Cell Sci 112:4615-4625.
46. Goeckeler ZM, Bridgman PC, Wysolmerski RB. 2008. Nonmuscle myosin II is responsible for maintaining endothelial cell basal tone and stress fiber integrity. Am J Physiol Cell Physiol 295:C994-C1006.
47. Goffin JM, Pittet P, Csucs G, Lussi JW, Meister J-J, Hinz B. 2006. Focal adhesion size controls tension-dependent recruitment of α-smooth muscle actin to stress fibers. J Cell Biol 172:259-268.
48. Goldman RD, Khuon S, Chou YH, Opal P, Steinert PM. 1996. The function of intermediate filaments in cell shape and cytoskeletal integrity. J Cell Biol 134:971-983.
49. Golomb E, Ma X, Jana SS, Preston YA, Kawamoto S, Shoham NG, Goldin E, Conti MA, Sellers JR, Adelstein RS. 2004. Identification and characterization of nonmuscle myosin II-C, a new member of the myosin II family. J Biol Chem 279:2800-2808.
50. Gomez EW, Chen QK, Gjorevski N, Nelson CM. 2010. Tissue geometry patterns epithelial-mesenchymal transition via intercellular mechanotransduction. J Cell Biochem 110:44-51.
51. Gonzales M, Weksler B, Tsuruta D, Goldman RD, Yoon KJ, Hopkinson SB, Flitney FW, Jones JCR. 2001. Structure and function of a vimentin-associated matrix adhesion in endothelial cells. Mol Biol Cell 12:85-100.
52. Guarino M. 2007. Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell Biol 39:2153-2160.
53. Gupta GP, Massagué J. 2006. Cancer metastasis: building a framework. Cell 127:679-695.
54. Halder G, Dupont S, Piccolo S. 2012. Transduction of mechanical and cytoskeletal cues by YAP and TAZ. Nat Rev Mol Cell Biol 13:591-600.
55. Hall A. 2012. Rho family GTPases. Biochem Soc Trans 40:1378-1382.
56. Hannigan M, Zhan L, Ai Y, Huang CK. 1998. The role of p38 MAP kinase in TGF-beta1-induced signal transduction in human neutrophils. Biochem Biophys Res Commun 246:55-58.
57. Haynes J, Srivastava J, Madson N, Wittmann T, Barber DL. 2011. Dynamic actin remodeling during epithelial-mesenchymal transition depends on increased moesin expression. Mol Biol Cell 22:4750-4764.
58. Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, Johnson RL, Martin JF. 2011. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 332:458-461.
59. Hedges JC, Dechert MA, Yamboliev IA, Martin JL, Hickey E, Weber LA, Gerthoffer WT. 1999. A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration. J Biol Chem 274:24211-24219.
60. Helfand BT, Mendez MG, Pugh J, Delsert C, Goldman RD. 2003. A role for intermediate filaments in determining and maintaining the shape of nerve cells. Mol Biol Cell 14:5069-5081.
61. Helfman DM, Levy ET, Berthier C, Shtutman M, Riveline D, Grosheva I, Lachish-Zalait A, Elbaum M, Bershadsky AD. 1999. Caldesmon inhibits nonmuscle cell contractility and interferes with the formation of focal adhesions. Mol Biol Cell 10:3097-3112.
62. Hernandez P, Tirnauer JS. 2010. Tumor suppressor interactions with microtubules: keeping cell polarity and cell division on track. Dis Model Mech 3:304-315.
63. Higgins DF, Kimura K, Bernhardt WM, Shrimanker N, Akai Y, Hohenstein B, Saito Y, Johnson RS, Kretzler M, Cohen CD, et al. 2007. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 117:3810-3820.
64. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C. 2001. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 12:2730-2741.
65. Hinz B, Dugina V, Ballestrem C, Wehrle-Haller B, Chaponnier C. 2003. α-Smooth muscle actin is crucial for focal adhesion maturation in myofibroblasts. Mol Biol Cell 14:2508-2519.
66. Huot J, Houle F, Rousseau S, Deschesnes RG, Shah GM, Landry J. 1998. SAPK2/p38-dependent F-actin reorganization regulates early membrane blebbing during stress-induced apoptosis. J Cell Biol 143:1361-1373.
67. Imajo M, Miyatake K, Iimura A, Miyamoto A, Nishida E. 2012. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/beta-catenin signalling. Embo J 31:1109-1122.
68. Ivaska J, Pallari H-M, Nevo J, Eriksson JE. 2007. Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res 313:2050-2062.
69. Ivaska J, Vuoriluoto K, Huovinen T, Izawa I, Inagaki M, Parker PJ. 2005. PKCε-mediated phosphorylation of vimentin controls integrin recycling and motility. Embo J 24:3834-3845.
70. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. 2002. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341-350.
71. Jackson BW, Grund C, Winter S, Franke WW, Illmensee K. 1981. Formation of cytoskeletal elements during mouse embryogenesis: II. Epithelial Differentiation and intermediate-Sized Filaments in Early Postimplantation Embryos. Differentiation 20:203-216.
72. Jiang Q, Huang R, Cai S, Wang C-LA. 2010. Caldesmon regulates the motility of vascular smooth muscle cells by modulating the actin cytoskeleton stability. J Biomed Sci 17:6.
73. Kadrmas JL, Beckerle MC. 2004. The LIM domain: From the cytoskeleton to the nucleus. Nat Rev Mol Cell Bio 5:920-931.
74. Kaimori A, Potter J, Kaimori J-y, Wang C, Mezey E, Koteish A. 2007. Transforming growth factor-β1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem 282:22089-22101.
75. Kalluri R, Weinberg RA. 2009. The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420-1428.
76. Kim-Kaneyama JR, Suzuki W, Ichikawa K, Ohki T, Kohno Y, Sata M, Nose K, Shibanuma M. 2005. Uni-axial stretching regulates intracellular localization of Hic-5 expressed in smooth-muscle cells in vivo. J Cell Sci 118:937-949.
77. Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, Sheppard D, Chapman HA. 2006. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 103:13180-13185.
78. Kim KK, Wei Y, Szekeres C, Kugler MC, Wolters PJ, Hill ML, Frank JA, Brumwell AN, Wheeler SE, Kreidberg JA, et al. 2009. Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. J Clin Invest 119:213-224.
79. Kolosova I, Nethery D, Kern JA. 2011. Role of Smad2/3 and p38 MAP kinase in TGF-β1-induced epithelial-mesenchymal transition of pulmonary epithelial cells. J Cell Physiol 226:1248-1254.
80. König K, Meder L, Kröger C, Diehl L, Florin A, Rommerscheidt-Fuss U, Kahl P, Wardelmann E, Magin TM, Buettner R. 2013. Loss of the keratin cytoskeleton is not sufficient to induce epithelial mesenchymal transition in a novel KRAS driven sporadic lung cancer mouse model. PLoS One 8:e57996
81. Konsavage WM Jr., Yochum GS. 2013. Intersection of Hippo/YAP and Wnt/beta-catenin signaling pathways. Acta Biochim Biophys Sin (Shanghai) 45:71-79.
82. Kovacs M, Toth J, Hetenyi C, Malnasi-Csizmadia A, Sellers JR. 2004. Mechanism of blebbistatin inhibition of myosin II. J Biol Chem 279:35557-35563.
83. Lamouille S, Xu J, Derynck R. 2014. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15:178-196.
84. Lang SH, Hyde C, Reid IN, Hitchcock IS, Hart CA, Bryden AA, Villette JM, Stower MJ, Maitland NJ. 2002. Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma. Prostate 52:253-263.
85. Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, Qing J, Smith SM, Derynck R. 2007. TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. Embo J 26:3957-3967.
86. Lehrer SS, Morris EP. 1982. Dual effects of tropomyosin and tropomim-tropomyosin on actomyosin subfragment-1 ATPase. J Biol Chem 257:8073-8080.
87. Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH, Zhao S, Xiong Y, Guan KL. 2008. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol 28:2426-2436.
88. Lin JJC, Li Y, Eppinga RD, Wang QC, Jin JP. 2009. Roles of caldesmon in cell motility and actin cytoskeleton remodeling. In: Jeon KW, editor. International Review of Cell and Molecular Biology, Vol 274. San Diego: Elsevier Academic Press Inc. pp 1-68.
89. Lindsey S, Langhans SA. 2014. Crosstalk of Oncogenic Signaling Pathways during Epithelial-Mesenchymal Transition. Front Oncol 4:358
90. Lu L, Oswald SJ, Ngu H, Yin FCP. 2008. Mechanical Properties of Actin Stress Fibers in Living Cells. Biophys J 95:6060-6071.
91. Mana-Capelli S, Paramasivam M, Dutta S, McCollum D. 2014. Angiomotins link F-actin architecture to Hippo pathway signaling. Mol Biol Cell 25:1676-1685.
92. Masszi A, Di Ciano C, Sirokmány G, Arthur WT, Rotstein OD, Wang J, McCulloch CA, Rosivall L, Mucsi I, Kapus A. 2003. Central role for Rho in TGF-β1-induced α-smooth muscle actin expression during epithelial-mesenchymal transition. Am J Physiol Renal Physiol 284:F911-F924.
93. Masszi A, Kapus A. 2010. Organ fibrosis: when epithelia are muscled to change. Cell Cycle 9:2263-2264.
94. Masszi A, Speight P, Charbonney E, Lodyga M, Nakano H, Szaszi K, Kapus A. 2010. Fate-determining mechanisms in epithelial-myofibroblast transition: major inhibitory role for Smad3. J Cell Biol 188:383-399.
95. McGrail DJ, Mezencev R, Kieu QM, McDonald JF, Dawson MR. 2015. SNAIL-induced epithelial-to-mesenchymal transition produces concerted biophysical changes from altered cytoskeletal gene expression. Faseb J 29:1280-1289.
96. Mendez MG, Kojima S-I, Goldman RD. 2010. Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. Faseb J 24:1838-1851.
97. Miettinen PJ, Ebner R, Lopez AR, Derynck R. 1994. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells-involvement of type-I receptors. J Cell Biol 127:2021-2036.
98. Miralles F, Posern G, Zaromytidou AI, Treisman R. 2003. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113:329-342.
99. Mise N, Savai R, Yu H, Schwarz J, Kaminski N, Eickelberg O. 2012. Zyxin is a transforming growth factor-beta (TGF-beta)/Smad3 target gene that regulates lung cancer cell motility via integrin alpha5beta1. J Biol Chem 287:31393-31405.
100. Mori M, Nakagami H, Koibuchi N, Miura K, Takami Y, Koriyama H, Hayashi H, Sabe H, Mochizuki N, Morishita R, et al. 2009. Zyxin mediates actin fiber reorganization in epithelial-mesenchymal transition and contributes to endocardial morphogenesis. Mol Biol Cell 20:3115-3124.
101. Morita T, Mayanagi T, Sobue K. 2007. Dual roles of myocardin-related transcription factors in epithelial-mesenchymal transition via slug induction and actin remodeling. J Cell Biol 179:1027-1042.
102. Musch A. 2004. Microtubule organization and function in epithelial cells. Traffic 5:1-9.
103. O'Connor JW, Gomez EW. 2013. Cell Adhesion and Shape Regulate TGF-Beta1-Induced Epithelial-Myofibroblast Transition via MRTF-A Signalling. PLoS One 8:e83188
104. O'Connor JW, Gomez EW. 2014. Biomechanics of TGFbeta-induced epithelial-mesenchymal transition: implications for fibrosis and cancer. Clin Transl Med 3:23
105. O'Connor JW, Riley PN, Nalluri SM, Ashar PK, Gomez EW. 2015. Matrix rigidity mediates TGFbeta1-induced epithelial-myofibroblast transition by controlling cytoskeletal organization and MRTF-A localization. J Cell Physiol 230:1829-1839.
106. Olmeda D, Jorda M, Peinado H, Fabra A, Cano A. 2007. Snail silencing effectively suppresses tumour growth and invasiveness. Oncogene 26:1862-1874.
107. Oyanagi J, Ogawa T, Sato H, Higashi S, Miyazaki K. 2012. Epithelial-mesenchymal transition stimulates human cancer cells to extend microtubule-based invasive protrusions and suppresses cell growth in collagen gel. PLoS One 7:e53209
108. Pellegrin S, Mellor H. 2007. Actin stress fibres. J Cell Sci 120:3491-3499.
109. Pichon S, Bryckaert M, Berrou E. 2004. Control of actin dynamics by p38 MAP kinase - Hsp27 distribution in the lamellipodium of smooth muscle cells. J Cell Sci 117:2569-2577.
110. Pignatelli J, Tumbarello DA, Schmidt RP, Turner CE. 2012. Hic-5 promotes invadopodia formation and invasion during TGF-beta-induced epithelial-mesenchymal transition. J Cell Biol 197:421-437.
111. Posern G, Treisman R. 2006. Actin' together: serum response factor, its cofactors and the link to signal transduction. Trends Cell Biol 16:588-596.
112. Raval GN, Bharadwaj S, Levine EA, Willingham MC, Geary RL, Kute T, Prasad GL. 2003. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors. Oncogene 22:6194-6203.
113. Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh ST, Lee HB. 2005. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 16:667-675.
114. Sahlgren C, Gustafsson MV, Jin S, Poellinger L, Lendahl U. 2008. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA 105:6392-6397.
115. Saika S, Yamanaka O, Ikeda K, Kim-Mitsuyama S, Flanders KC, Yoo J, Roberts AB, Nishikawa-Ishida I, Ohnishi Y, Muragaki Y, et al. 2005. Inhibition of p38MAP kinase suppresses fibrotic reaction of retinal pigment epithelial cells. Lab Invest 85:838-850.
116. Satelli A, Li S. 2011. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 68:3033-3046.
117. Schneider D, Baronsky T, Pietuch A, Rother J, Oelkers M, Fichtner D, Wedlich D, Janshoff A. 2013. Tension monitoring during epithelial-to-mesenchymal transition links the switch of phenotype to expression of moesin and cadherins in NMuMG cells. PLoS One 8:e80068
118. Schneider D, Janshoff A. 2012. Inhibition of actin dynamics during epithelial-to-mesenchymal transition. Biochem Biophys Res Commun 419:221-225.
119. Sebe A, Leivonen S-K, Fintha A, Masszi A, Rosivall L, Kähäri V-M, Mucsi I. 2008. Transforming growth factor-β-induced alpha-smooth muscle cell actin expression in renal proximal tubular cells is regulated by p38β mitogen-activated protein kinase, extracellular signal-regulated protein kinase1, 2 and the Smad signalling during epithelial-myofibroblast transdifferentiation. Nephrol Dial Transplant 23:1537-1545.
120. Shankar J, Nabi IR. 2015. Actin cytoskeleton regulation of epithelial mesenchymal transition in metastatic cancer cells. PLoS One 10:e0119954
121. Shi YG, Massague J. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685-700.
122. Simpson CL, Patel DM, Green KJ. 2011. Deconstructing the skin: cytoarchitectural determinants of epidermal morphogenesis. Nat Rev Mol Cell Biol 12:565-580.
123. Sobue K, Sellers JR. 1991. Caldesmon, a novel regulatory protein in smooth-muscle and nonmuscle actomyosin systems. J Biol Chem 266:12115-12118.
124. Speight P, Nakano H, Kelley TJ, Hinz B, Kapus A. 2013. Differential topical susceptibility to TGFbeta in intact and injured regions of the epithelium: key role in myofibroblast transition. Mol Biol Cell 24:3326-3336.
125. Steinert P, Roop D. 1988. Molecular and cellular biology of intermediate filaments. Annu Rev Biochem 57:593-625.
126. Strippoli R, Benedicto I, Perez Lozano ML, Cerezo A, Lopez-Cabrera M, del Pozo MA. 2008. Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-kappaB/Snail1 pathway. Dis Model Mech 1:264-274.
127. Swaminathan V, Mythreye K, O'Brien ET, Berchuck A, Blobe GC, Superfine R. 2011. Mechanical Stiffness Grades Metastatic Potential in Patient Tumor Cells and in Cancer Cell Lines. Cancer Res 71:5075-5080.
128. Tan JL, Tien J, Pirone DM, Gray DS, Bhadriraju K, Chen CS. 2003. Cells lying on a bed of microneedles: An approach to isolate mechanical force. P Natl Acad Sci USA 100:1484-1489.
129. Tavares AL, Mercado-Pimentel ME, Runyan RB, Kitten GT. 2006. TGF beta-mediated RhoA expression is necessary for epithelial-mesenchymal transition in the embryonic chick heart. Dev Dyn 235:1589-1598.
130. Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442-454.
131. Thiery JP, Acloque H, Huang RY, Nieto MA. 2009. Epithelial-mesenchymal transitions in development and disease. Cell 139:871-890.
132. Thoelking G, Reiss B, Wegener J, Oberleithner H, Pavenstaedt H, Riethmuller C. 2010. Nanotopography follows force in TGF-beta1 stimulated epithelium. Nanotechnology 21:265102
133. Tsapara A, Luthert P, Greenwood J, Hill CS, Matter K, Balda MS. 2010. The RhoA activator GEF-H1/Lfc is a transforming growth factor-beta target gene and effector that regulates alpha-smooth muscle actin expression and cell migration. Mol Biol Cell 21:860-870.
134. Tsukada T, Fushida S, Harada S, Terai S, Yagi Y, Kinoshita J, Oyama K, Tajima H, Ninomiya I, Fujimura T, et al. 2013. Low-dose paclitaxel modulates tumour fibrosis in gastric cancer. Int J Oncol 42:1167-1174.
135. Tumbarello DA, Brown MC, Hetey SE, Turner CE. 2005. Regulation of paxillin family members during epithelial-mesenchymal transformation: a putative role for paxillin δ. J Cell Sci 118:4849-4863.
136. Tumbarello DA, Turner CE. 2007. Hic-5 contributes to epithelial-mesenchymal transformation through a RhoA/ROCK-dependent pathway. J Cell Physiol 211:736-747.
137. Valles AM, Boyer B, Badet J, Tucker GC, Barritault D, Thiery JP. 1990. Acidic Fibroblast growth-factor is a modulator of epithelial plasticity in a rat bladder-carcinoma cell-line. Proc Natl Acad Sci USA 87:1124-1128.
138. Vardouli L, Moustakas A, Stournaras C. 2005. LIM-kinase 2 and cofilin phosphorylation mediate actin cytoskeleton reorganization induced by transforming growth factor-beta. J Biol Chem 280:11448-11457.
139. Varelas X, Sakuma R, Samavarchi-Tehrani P, Peerani R, Rao BM, Dembowy J, Yaffe MB, Zandstra PW, Wrana JL. 2008. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol 10:837-848.
140. Varelas X, Samavarchi-Tehrani P, Narimatsu M, Weiss A, Cockburn K, Larsen BG, Rossant J, Wrana JL. 2010. The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-beta-SMAD pathway. Dev Cell 19:831-844.
141. Vicente-Manzanares M, Ma XF, Adelstein RS, Horwitz AR. 2009. Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat Rev Mol Cell Biol 10:778-790.
142. Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi J, Nevo J, Gjerdrum C, Tiron C, Lorens J, Ivaska J. 2011. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 30:1436-1448.
143. Wang FL, Wang Y, Wong WK, Liu Y, Addivinola FJ, Liang P, Chen LB, Kantoff PW, Pardee AB. 1996. Two differentially expressed genes in normal human prostate tissue and in carcinoma. Cancer Res 56:3634-3637.
144. Wipff PJ, Rifkin DB, Meister JJ, Hinz B. 2007. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol 179:1311-1323.
145. Wu Y, Zhang X, Salmon M, Lin X, Zehner ZE. 2007. TGFbeta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and Sp1 family members. Biochim Biophys Acta 1773:427-439.
146. Wu Z-Q, Li X-Y, Hu CY, Ford M, Kleer CG, Weiss SJ. 2012. Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression. Proc Natl Acad Sci USA 109:16654-16659.
147. Xie L, Law BK, Aakre ME, Edgerton M, Shyr Y, Bhowmick NA, Moses HL. 2003. Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line. Breast Cancer Res 5:R187-R198.
148. Xie L, Law BK, Chytil AM, Brown KA, Aakre ME, Moses HL. 2004. Activation of the Erk Pathway Is Required for TGF-β1-Induced EMT In Vitro. Neoplasia 6:603-610.
149. Xu J, Lamouille S, Derynck R. 2009. TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19:156-172.
150. Yilmaz M, Christofori G. 2009. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metast Rev 28:15-33.
151. Yook JI, Li XY, Ota I, Fearon ER, Weiss SJ. 2005. Wnt-dependent regulation of the E-cadherin repressor snail. J Biol Chem 280:11740-11748.
152. Yoshida T, Ozawa Y, Kimura T, Sato Y, Kuznetsov G, Xu S, Uesugi M, Agoulnik S, Taylor N, Funahashi Y, et al. 2014. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states. Br J Cancer 110:1497-1505.
153. Yu L, Hébert MC, Zhang YE. 2002. TGF-β receptor-activated p38 MAP kinase mediates Smad-independent TGF-β responses. Embo J 21:3749-3759.
154. Zavadil J, Bitzer M, Liang D, Yang YC, Massimi A, Kneitz S, Piek E, Bottinger EP. 2001. Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc Natl Acad Sci USA 98:6686-6691.
155. Zavadil J, Bottinger EP. 2005. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24:5764-5774.
156. Zeisberg M, Bonner G, Maeshima Y, Colorado P, Muller GA, Strutz F, Kalluri R. 2001. Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation. Am J Pathol 159:1313-1321.
157. Zeisberg M, Kalluri R. 2004. The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med (Berl) 82:175-181.
158. Zhang Q, Helfand BT, Jang TL, Zhu LJ, Chen L, Yang XJ, Kozlowski J, Smith N, Kundu SD Yang G., et al. 2009. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy. Clin Cancer Res 15:3557-3567.